Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Hip, knees, Conceptual,3d,Human,Man,Anatomy,Or,Health,Design,,Joint,Or

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

The orthopedic implant maker reported sales of $2.08 billion, up 7% on a reported basis, up 5.4% on a constant currency basis, and 2.8% on an organic constant currency basis, beating the consensus of $2.05 billion.